Part 6: Detection and Prevention of Foot Problems in Type 2 Diabetes

Part 6: Detection and Prevention of Foot Problems in Type 2 Diabetes Part 6: Detection and Prevention of Foot Problems in Type 2 Diabetes

australiandiabetescouncil.com
from australiandiabetescouncil.com More from this publisher
10.07.2015 Views

McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE, Smith DG, Pecoraro RF. The independentcontributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks?Diabetes Care 1995;18:216-9.Meade TW, Gardner MJ, Cannon P, Richardson PC. Observer variability in recording peripheralpulses. Br Heart J 1968;30:661-5.Moss SE, Klein R, Klein B. Long-term incidence of lower-extremity amputations in a diabeticpopulation. Arch Fam Med 1996;5:391-8.NADC. ANDIAB. Australian National Diabetes Information Audit and Benchmarking. Final report.National Association of Diabetes Centres; Sydney: 2000.Orchard TJ, Strandness DE Jr. Assessment of peripheral vascular disease in diabetes. Report andrecommendations of an international workshop sponsored by the American Heart Association and theAmerican Diabetes Association 18-20 September 1992, New Orleans, Louisiana. Diabetes Care1993;16:1199-209.Payne CB. Diabetes-related lower-limb amputations in Australia. MJA 2000;173:352-4.Pecoraro RE, Reiber GE. Classification of wounds in diabetic amputees. Wounds 1990;2:65-73. (Can'tfind)Pichert JW, Penha ML. Institutionalization of diabetes care and education programs: A tale of twocities. Diabetes Educ 1993;19:273-7.Pirart J. Degenerative diabetic complications. Is persistent hyperglycemia more dangerous than wideglycemic fluctuations? Nouv Presse Med 1978;7:4031-5.Plummer ES, Albert SG. Foot care assessment in patients with diabetes: A screening algorithm forpatient education and referral. Diabetes Educ 1995;21:47-51.Reiber GE. Epidemiology of the diabetic foot. In: Levin ME, O'Neal LW, Bowker JH. The DiabeticFoot. Mosby Year Book, St Louis. 1993;1-5.Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg 1998;176(Suppl2A):S5-10.Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus.A case-control study. Ann Intern Med 1992;117:97-105.Reiber GE, Smith DG, Boone DA, del Aguila M, Borchers RE, Mathews D, Joseph AW, Burgess EM.Design and pilot testing of the DVA/Seattle Footwear System for diabetic patients with footinsensitivity. J Rehabil Res Dev 1997;34:1-8.Reiber GE, Smith DG, Wallace CM, Vath CA, Sullivan K, Hayes S, Yu O, Martin D, Maciejewski M.Footwear used by individuals with diabetes and a history of foot ulcer. J Rehabil Res Dev2002b;39:615-22.Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA, Boulton AJ. Causal pathwaysfor incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care1999;22:157-62.Shaw JE, Boulton AJ. The pathogenesis of diabetic foot problems: an overview. Diabetes1997;46(Suppl 2):S58-61.Sims DS Jr, Cavanagh PR, Ulbrecht JS. Risk factors in the diabetic foot. Recognition and management.Phys Ther 1988;68:1887-902.112

Sugarman JR, Reiber GE, Baumgardner G, Prela CM, Lowery J. Use of the therapeutic footwearbenefit among diabetic medicare beneficiaries in three states, 1995. Diabetes Care 1998;21:777-81.Tapp RJ, Shaw JE, de Courten MP, Dunstan DW, Welborn TA, Zimmet PZ. Foot complications nType 2 diabetes: an Australian population-based study. Diabet Med 2003;20:105-13.Tkac I, Bril V. Glycemic control is related to the electrophysiologic severity of diabetic peripheralsensorimotor polyneuropathy. Diabetes Care 1998;21:1749-52.Tovey FI. The manufacture of diabetic footwear. Diabet Med 1984;1:69-71.UKPDS 33. Intensive blood-glucose control with sulphonylureas or insulin compared withconventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet1998;352:837-53.Veves A, Murray HJ, Young MJ, Boulton AJ. The risk of foot ulceration in diabetic patients with highfoot pressure: a prospective study. Diabetologia 1992;35:660-3.Young MJ, Veves A, Boulton AJ. The diabetic foot: aetiopathogenesis and management. DiabetesMetab Rev 1993a;9:109-27.Young M, Matthews C. Neuropathy screening: can we achieve our ideals? Diabetic Foot 1998;1:22-5.Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of theprevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population.Diabetologia 1993b;36:150-4.113

Sugarman JR, Reiber GE, Baumgardner G, Prela CM, Lowery J. Use <strong>of</strong> the therapeutic footwearbenefit among diabetic medicare beneficiaries <strong>in</strong> three states, 1995. <strong>Diabetes</strong> Care 1998;21:777-81.Tapp RJ, Shaw JE, de Courten MP, Dunstan DW, Welborn TA, Zimmet PZ. <strong>Foot</strong> complications n<strong>Type</strong> 2 diabetes: an Australian population-based study. Diabet Med 2003;20:105-13.Tkac I, Bril V. Glycemic control is related to the electrophysiologic severity <strong>of</strong> diabetic peripheralsensorimotor polyneuropathy. <strong>Diabetes</strong> Care 1998;21:1749-52.Tovey FI. The manufacture <strong>of</strong> diabetic footwear. Diabet Med 1984;1:69-71.UKPDS 33. Intensive blood-glucose control with sulphonylureas or <strong>in</strong>sul<strong>in</strong> compared withconventional treatment <strong>and</strong> risk <strong>of</strong> complications <strong>in</strong> patients with type 2 diabetes (UKPDS 33). Lancet1998;352:837-53.Veves A, Murray HJ, Young MJ, Boulton AJ. The risk <strong>of</strong> foot ulceration <strong>in</strong> diabetic patients with highfoot pressure: a prospective study. Diabetologia 1992;35:660-3.Young MJ, Veves A, Boulton AJ. The diabetic foot: aetiopathogenesis <strong>and</strong> management. <strong>Diabetes</strong>Metab Rev 1993a;9:109-27.Young M, Matthews C. Neuropathy screen<strong>in</strong>g: can we achieve our ideals? Diabetic <strong>Foot</strong> 1998;1:22-5.Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study <strong>of</strong> theprevalence <strong>of</strong> diabetic peripheral neuropathy <strong>in</strong> the United K<strong>in</strong>gdom hospital cl<strong>in</strong>ic population.Diabetologia 1993b;36:150-4.113

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!